Clinical Trial Update: STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS [Phase 1]

View source ↗

Summary

Phase 1 study of talazoparib monotherapy in Chinese participants with advanced solid tumors has completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2023-10-10